首页> 外文期刊>The Canadian journal of cardiology >Treatment of In-Stent Restenosis With Bioresorbable Vascular Scaffolds: Optical Coherence Tomography Insights
【24h】

Treatment of In-Stent Restenosis With Bioresorbable Vascular Scaffolds: Optical Coherence Tomography Insights

机译:生物可吸收的血管支架治疗支架内再狭窄:光学相干断层扫描的见解。

获取原文
获取原文并翻译 | 示例
           

摘要

The role of the bioresorbable vascular scaffold (BVS) in patients with instent restenosis (ISR) remains unsettled. We present optical coherence tomography (OCT) findings in a series of 15 consecutive patients undergoing treatment of ISR with a BVS under systematic OCT guidance. OCT disclosed severe ISR in all patients (minimal lumen area [MLA], 1.3 +/- 0.6 mm(2); stent obstruction 80% +/- 10%). After the procedure, OCT MLA was 6.4 +/- 2 mm(2) with a final BVS expansion of 79% +/- 19%. "Angiographically silent" edge dissections (n = 6), intradevice dissections (n = 3), tissue prolapse (n = 3), and malapposition (n = 3) were also readily visualized. These findings underscore the diagnostic value of OCT in patients undergoing BVS implantation for ISR.
机译:生物可吸收性血管支架(BVS)在支架内再狭窄(ISR)患者中的作用尚未确定。我们介绍了在系统性OCT指导下接受BVS治疗ISR的15例连续患者中的光学相干断层扫描(OCT)结果。 OCT在所有患者中均披露了严重的ISR(最小管腔面积[MLA],1.3 +/- 0.6 mm(2);支架阻塞80%+/- 10%)。手术后,OCT MLA为6.4 +/- 2 mm(2),最终BVS膨胀为79%+/- 19%。 “血管造影无声”边缘解剖(n = 6),器械内解剖(n = 3),组织脱垂(n = 3)和贴壁不良(n = 3)也很容易观察到。这些发现强调了OCT在接受BVS植入的ISR患者中的诊断价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号